Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome

Journal of Interventional Cardiology

Volumn 18, Issue 2, 2005, Pages 139-144

  Ziakas, Antonios ^a,b   Gavrilidis, Stavros ^a   Makris, Pantelis ^a   Louridas, George ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THROMBOCYTE COUNT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; VASCULAR PATENCY;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY STENOSIS; HEPARIN; HUMANS; MALE; THROMBOCYTOPENIA; THROMBOSIS;

EID: 18744373603     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.04070.x     Document Type: Article

References (22)

1. Ananthasubramanian K, Shurafa M, Prasad A. Heparin induced thrombocytopenia and thrombosis. Prog Cardiovasc Dis 2000;42:247-260.
2. Warkentin TE, Kelton JG. A 14 year study of heparin induced thrombocytopenia. Am J Med 1996;101:502-507.
3. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin induced thrombocytopenia are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-88.
4. Warkentin TE. Clinical picture of heparin induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin Induced Thrombocytopenia. New York: Marcel Decker, 2000:43-80.
5. Warkentin TE, Kelton JG. Temporal aspects of heparin induced thrombocytopenia. New Engl J Med 2001;344:1286-1292.
6. Sakai K, Oda H, Honsako A, et al. Obstinate thrombosis during percutaneous coronary intervention in a case with heparin induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy. Catheter Cardiovasc Interven 2003;59:351-354.
7. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin induced thrombocytopenia. New Engl J Med 1987;316:581-589.
8. Choi D, Jang Y, Lee BK, et al. Stenting with intravenous abciximab infusion for the treatment of left main coronary artery thrombosis during coronary angioplasty. J Invasive Cardiol 2001;13(2):107-110.
9. Sanz AJ, Hernandez F, Tascon JC. Thrombotic occlusion of the left main coronary artery during coronary angiography. J Invasive Cardiol 2002;14(7):426-429.
10. Laumenthal FC, Grosch B, Szurawitzki, G, et al. Heparin induced thrombocytopenia type II with early aortocoronary bypass occlusion and stent thrombosis after PTCA of the RCA-treatment with lepirudin and abciximab during recanalization of the RCA. Z Cardiol 1999;88(2):141-146.
11. Gupta BK, Savage MP, Brest AN. Acute myocardial infarction during coronary angioplasty associated with heparin induced thrombocytopenia. Cathet Cardiovasc Diagn 1995;35(1):42-46.
12. Manfredi JA, Wall RP, Sane DC, et al. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: Case reports. Catheter Cardiovasc Interven 2001;52:468-472.
13. Lewis BE, Wallis DE, Bercowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001;103:1838-1843.
14. Lewis BE, Ferguson JJ, Grassman ED, et al. Successful coronary interventions performed with argatroban anticoagulation in patients with heparin-induced thrombocytopenia and thrombosis syndrome. J Invasive Cardiol 1996;8:410-417.
15. Singh M, Tiede DJ, Mathew V, et al. Rheolytic thrombectomy with Angiojet in thrombus-containing lesions. Catheter Cardiovasc Interven 2002;56(1):1-7.
16. Antoniucci D, Valenti R, Migliorini A, et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2004;93(8):1033-1035.
17. Stone GW, Cox DA, Low R, et al. for the X-TRACT Investigators. Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: Results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) study. Catheter Cardiovasc Interven 2003;58(4):419-427.
18. Orrego PS, Delgado A, Piccalo G, et al. Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: Single-center experience. Catheter Cardiovasc Interven 2003;60(2):152-158.
19. Muhlestein JB, Karagounis LA, Treehan S, et al. "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997:30(7):1729-1734.
20. Bartorelli AL, Trabattoni D, Galli S, et al. Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA. Catheter Cardiovasc Interven 1999;48(2):211-213.
21. Thuraisingham S, Tan KH. Dissolution of thrombus formed during direct coronary angioplasty with a single 10 mg intracoronary bolus dose of abciximab. Int J Clin Pract 1999;53(8):604-607.
22. Song JK, Niimi Y, Fernandez PM, et al. Thrombus formation during intracranial aneurysm coil placement: Treatment with intra-arterial abciximab. Am J Neuroradiol. 2004;25(7):1147-1153.